RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease

Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease

Mark, T., Mucha, L., Want, S. S., Cuffel, B., McRae, T., & Del Valle, M. (2008). Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease. Journal of Managed Care Pharmacy, 22(1), 451-461. [PMID: 18597574]. https://doi.org/10.18553/jmcp.2008.14.5.451

Abstract

Sustained treatment with a cholinesterase inhibitor (ChEI) is used in the management of the symptoms of Alzheimer's disease (AD). However, the characteristic declines in learning and memory seen in AD may erode the patient's ability to adhere to medication regimens with or without caregiver support.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Urinary cadmium and stroke - a case-cohort study in Danish never-smokers
Article

α-[Amino(4-aminophenyl)thio]methylene-2-(trifluoromethyl)benzeneacetonitrile; Configurational equilibria in solution
Article

Building back better to avert a learning catastrophe
Article

Rational design of cannabinoid type-1 receptor allosteric modulators